Drug Type Small molecule drug |
Synonyms G 5758, G5758 |
Target |
Action inhibitors |
Mechanism IRE1 inhibitors(Serine/threonine-protein kinase/endoribonuclease IRE1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H24F4N6O3S |
InChIKeyRBOAUACOQMQNBF-ROUUACIJSA-N |
CAS Registry2413455-99-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | United States | 15 May 2024 |